news Archives - Page 40 of 100 - Journal for Clinical Studies

Current Edition

Europe

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of c...

22 November 2018 Europe | news

Continue Reading →

news

‘Breakthrough’ treatment for peanut allergy awaits FDA check

Peanut allergy makes life more difficult for the millions of people who live with it. "Possible traces" of peanuts in foods pose a constant hidden threat for them, bu...

22 November 2018 news | North America

Continue Reading →

Europe

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. New research finds a safe way to boost the effects of radiatio...

22 November 2018 Europe | news | Regional News

Continue Reading →

Europe

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company develo...

22 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Quanticate Sponsors Research into Response-Adaptive Trial Design

LONDON (UK) - Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD p...

22 November 2018 Europe | news

Continue Reading →

Australasia

Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye

Melbourne, Australia, November 19, 2018 / B3C newswire / -- Bionic Vision Technologies Pty Ltd (BVT) today announced medical researchers had successfully restored a s...

22 November 2018 Australasia | news

Continue Reading →

Australasia

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provider of...

Continue Reading →

news

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. Cancer continues to be one of the top causes of death in the Uni...

15 November 2018 news | North America

Continue Reading →

Asia Pacific

EXUMA Biotech acquires strategic CAR-T assets

EXUMA Biotech integrates BioAtla's conditionally active biologic (CAB) protein therapeutic technology with F1 Oncology's proprietary CAR-T technologies to develop and...

15 November 2018 Asia Pacific | news

Continue Reading →

Europe

Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics

NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today an...

15 November 2018 Europe | news

Continue Reading →